A monoclonal antibody recognizing an antigenic determinant on the env transmembrane protein, gp32 of simian immunodeficiency virus SIVMAC has been developed and designated SF8/5E11. The reactivity of this antibody was found to be type specific, since it did not cross-react with either SIVSMM or SIVMNe transmembrane proteins. The availability of both this antibody and the complete nucleotide sequence of SIVMAC allowed us to define the organization of the env gene products of this virus. Radiolabel sequencing of the amino termini of both gpl60 and gp32 confirmed the positions of both cleavage sites predicted by alignment of the inferred amino acid sequences of the SIVMAC and human immunodeficiency virus type 1 env genes. The cleavage site between the signal peptide and the external env glycoprotein resides between the cysteine residue at position 21 and the threonine residue at position 22, starting from the first residue after the env gene initiator methionine. The env precursor polyprotein gpl60 is cleaved between arginine 526 and glycine 527 to give rise to the external glycoprotein and the transmembrane of SIVMAC.
The identification of human immunodeficiency virus type 1 (HIV-1) and the relevance of animal model systems to study the biology of the human T cell lymphotropic virus family have led to the characterization of a group of related simian retroviruses. Simian T cell lymphotropic virus type III now called simian immunodeficiency virus (SIV) has been isolated from various species of Old World primates, including macaques (SIVMAC; 2, 4), African green monkeys (SIVAGM; 13), and sooty mangabeys (SIVSMM; 6, 11, 12) . All macaque isolates obtained were from captive animals with immunodeficiency disease and possible exposure to either African green monkeys (4) or mangabeys (12) . SIVMAC induces symptoms similar to those of acquired immunodeficiency syndrome in infected macaques (4, 10) , but isolates from African green monkeys and mangabeys appear to be nonpathogenic in their natural hosts. Comparison of the genome of SIVMAC with those of known HIVs indicates that this virus is more closely related to HIV-2 than to HIV-1 (3, 5, 7) . The biological properties of SIVMAC and of HIV-1 and -2 are similar. SIVMAC viral proteins show size similarities and cross-reactivity with the gag, env, and nef proteins of HIV-1 (9). The major viral antigens of SIVMAC have been identified by radioimmunoprecipitation and sodium dodecyl sulphate-polyacrylamide gel electrophoretic (SDS-PAGE) analysis as proteins of 160, 120, 55, and 24 kilodaltons (kDa) in size (9) . gpl60 and gpl20 were shown to be glycosylated (9) , and by analogy with HIV-1, they were thought to correspond to the precursor and extracellular envelope glycoproteins of SIVMAC. Alignment of the inferred amino acid sequences of the SIVMAC and the human T cell lymphotropic type "IB env gene showed 38% homology overall and allowed prediction of the length of the signal peptide from the initiator methionine and the cleavage site between the external envelope glycoprotein and the transmembrane protein (3, 5) . The predicted SIVMAC transmembrane protein is 140 amino acids shorter than that of HIV-1 and should * Corresponding author.
correspond to the glycosylated 32-kDa protein recognized by infected monkey sera in immunoblots (8) . In the present study we describe the development of hybridomas secreting monoclonal antibodies to this 32-kDa protein. These antibodies were instrumental in the identification of the protein as the transmembrane portion of the envelope of SIVMAC and in precisely locating the cleavage site between the signal peptide and the envelope precursor gpl60 and that between the external glycoprotein gpl20 and the transmembrane protein gp32.
BALB/c mice were immunized with inoculations of detergent-disrupted SIVMAC. The successfully growing hybrids that resulted from fusion of the immune-mouse splenocytes with the murine myeloma line NS-1 were screened for secretion of antibody to SIVMAC proteins by enzyme-linked immunosorbent assay with disrupted SIVMAC as the antigen. Supernatants that scored positive in this assay were further tested by immunoblots against SIVMAC viral lysates and then against lysates from both SIVMAC-infected and uninfected HUT78 cells. Hybrids scoring positive on virus lysate and on virus-infected HUT78 cell lysate but negative on uninfected HUT78 lysate were cloned by limiting dilution. From all the virus-specific hybridomas, we selected the ones secreting antibodies to the diffuse 32-kDa protein recognized in electrophoretic separations, assuming that this might be an SIV envelope component. This protein was also recognized by SIV antibody-positive monkey sera. The antibody designated SF8/SE11 recognized a protein of approximately 32 kDa in size in both virus lysate and infected-cell lysate and was negative when tested against uninfected cells (Fig.  1A) . In addition to binding to the 32-kDa protein, this antibody also bound to a larger 160-kDa protein in strips with infected cell lysate. These findings agree with the assumption that the 32-kDa protein represents with a SIV-positive monkey serum and the immunoprecipitates obtained were subjected to SDS-PAGE analysis. Both antibodies precipitated a similar sized protein, gpl60, from the cellular extract (Fig. 1B) , while the SIV-positive monkey serum also immunoprecipitated the counterpart of the HIV-1 gpl20. No precipitation of the transmembrane protein was observed in either instance. This is not unusual, since precipitation of gp4l, the transmembrane protein of HIV-1 from [35S]cysteine-labeled infected cells cannot be demonstrated without prior enrichment of the glycoprotein fraction by lentil lectin-agarose chromatography (1, 15) .
After establishing the specificity of the SF8/5E11 antibody, it was of interest whether the same epitope recognized by SF8/5E11 was also present in other SIV isolates besides SIVMAC. Two other SIV isolates were tested: SIVSMM and SIVMNe. SIVSMM was isolated from asymptomatic sooty mangabeys and rhesus macaques that developed transmissible simian acquired immunodeficiency syndrome after inoculation with tissue homogenates from infected mangabeys (12) . SIVMNe was isolated from a pig-tailed macaque (Macaca nemestrina) with immune deficiency disorders that had died in 1982 with a poorly differentiated lymphoblastic lymphoma (2) . SF8/SE11 did not cross-react with the transmembrane protein of either virus in immunoblots. On the contrary, a monoclonal antibody raised against the major core protein p24 of SIVMAC efficiently bound to both SIVSMM and SIVMNe p24s (data not shown). Moreover, no cross-reactivity was observed when HIV-1 and HIV-2 were tested in the same assay (data not shown).
Since approximately 75 and 300 kDa in size (Fig. 2) . These proteins are not yet characterized. The radioactive gpl60 band was excised from the gel, eluted in water containing lmM phenylmethylsulfonyl fluoride and 10 nmole of apomyoglobin, and subjected to radiosequencing by Edman degradation. Valine was unambiguously assigned to positions 4, 6 , and 10, and phenylalanine was at position 7 for 20 cycles analyzed ( Fig. 3A and B) . The sequence determined was found to be a perfect match with the amino acid sequence predicted from the nucleotide sequence of the amino-terminal region of the SIVMAC env. Thus, as predicted, the gpl60 precipitated by SF8/SE11 corresponds to the SIV env precursor polyprotein. These results allowed us to precisely locate the cleavage site for the signal peptide and the external env glycoprotein between the cysteine residue at position 21 and the threonine residue at position 22 starting from the first residue after the env gene initiator methionine.
Following the same approach outlined above, the radioactive gp32 band was excised from the gel, eluted, and subjected to radiosequencing by Edman degradation. Valine was unambiguously assigned to positions 2 and 4 for 20 cycles analyzed (Fig. 3C) . The determined position of valine corresponded exactly to the amino acid sequence predicted from the nucleotide sequence of the carboxy-terminal region of the SIV env gene. These results allowed us to precisely identify gp32 as the transmembrane protein of SIV arising by cleavage of the precursor polypeptide between the arginine residue at position 526 and the glycine residue at position 527 (Fig. 4) . The cleavage is at a position analogous to the cleavage site in HIV-1, following conserved lysine-arginine residues (15).
In conclusion, we described the development of a hybridoma secreting monoclonal antibody to the env transmembrane protein of SIVMAC. The availability of both this antibody and the complete nucleotide sequence of SIVMAC (8, 9) (C) . The radioactive gpl60 and gp32 bands were excised from the gel and eluted in water containing 1 mM phenylmethylsulfonyl fluoride and 10 nmol of apomyoglobin. The eluted radiolabeled proteins were dialyzed at 4°C versus 5% acetic acid. The proteins were then subjected to radiolabeled sequencing (14) in a Beckman updated 890B spinning-cup Sequenator. Ten percent of cycles 2 and 11 were converted to the phenylthiohydantoin derivative of the amino acid and analyzed to ensure that the apomyoglobin protein was sequenced correctly. The remainder of the Sequenator fractions were transferred to scintillation vials, dried, dissolved in 10 ml of Aquassure (New England Nuclear Corp.), and counted for 10 min. The recovery of radioactivity in each cycle is given in the figure. Positive identifications are indicated by the open circles. this virus. Besides gp32 and gpl60, this antibody also immunoprecipitated two additional proteins of 75 and 300 kDa in apparent size, but their physical and chemical natures remain to be determined. In every instance, the monoclonal antibody recognized only a 32-kDa transmembrane protein and never the higher-molecular-weight transmembrane species that would result from translational readthrough of the in-frame termination codon occurring directly after the transmembrane protein (3, 5, 7) . This is consistent with the results obtained using sera from infected macaques 
